New reporting date, Vitrolife’s interim report and invitation to conference call on the interim report

Due to the merger between Vitrolife’s largest shareholder, Skanditek, and Bure, Vitrolife will change reporting date for the interim report January-September to Monday October 26, 2009. Invitation to attend Vitrolife’s conference call regarding presentation of the interim report for the period January-September 2009. The presentation will be held in English.

Time: Tuesday, October 27, 2009 at 10 a.m. CET. Registration can be done in advance under the following link: https://eventreg1.conferencing.com/webportal3/reg.html?Acc=830257&Conf=169038 or shortly before time of the conference starts on: Telephone number: +46 8 505 201 10 (Please quote 848837) Conference name: Vitrolife Vitrolife participants: Magnus Nilsson, CEO Eva Nilsagård, CFO The press release for Vitrolife’s interim report will be released at 3.00 p.m. CET on October 26. Before the conference call, slides will be available at the company web page, www.vitrolife.com, under the section Investors/News. A recorded version of the presentation will be available for seven days on number +46 8 505 203 33, access code 848837. Gothenburg October 19,2009 Magnus Nilsson CEO Queries should be addressed to: Eva Nilsagård, CFO, phone +46 31 721 80 13

About Us

Vitrolife is an international medical device Group. The Fertility product area develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes. Vitrolife has approximately 330 employees and the company’s products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX Stockholm, Mid Cap.

Subscribe

Documents & Links